Online citations, reference lists, and bibliographies.
← Back to Search

Dry Eye Disease: A Review Of Epidemiology In Taiwan, And Its Clinical Treatment And Merits

Yu-Kai Kuo, I-Chan Lin, Li-Nien Chien, Tzu-Yu Lin, Ying-Ting How, K. Chen, G. Dusting, Ching-Li Tseng
Published 2019 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Dry eye disease (DED) has become common on a global scale in recent years. There is a wide prevalence of DED in different countries based on various ethnicities and environment. DED is a multifactorial ocular disorder. In addition to advanced age and gender, such factors as living at high altitude, smoking, pterygium, prolonged use of consumer electronics or overingesting of caffeine or multivitamins are considered to be the major risk factors of DED. We report the DED epidemiology in Taiwan firstly in this article. According to the pathophysiological factors and changes inthe composition of the tear film in DED, it can be categorized into several subtypes, including lipid anomaly dry eye, aqueous tear deficiency, allergic and toxic dry eye among others. Each subtype has its own cause and disease management; therefore, it is important for ophthalmologists to identify the type through literature review and investigation. The management of DED, relies not only on traditional medications such as artificial tears, gels and ointments, but also newer treatment options such as acupuncture, SYL1001, and nanomedicine therapy. We also conducted a comprehensive literature review including common subtypes and treatment of DED. Clearly, more clinical trials are needed to assess the efficacy and safety of the various treatments and common subtypes of DED.
This paper references
10.1016/S0014-4835(03)00197-0
The influence of eyelid temperature on the delivery of meibomian oil.
Attila Nagymihályi (2004)
10.4103/tjo.tjo_15_18
Comparison of topical cyclosporine alone and topical loteprednol with cyclosporine in moderate dry eye in Indian population: A prospective study
S. Singla (2019)
10.1097/ICL.0b013e31822563be
Effects of Topical Cyclosporine A Plus Artificial Tears Versus Artificial Tears Treatment on Conjunctival Goblet Cell Density in Dysfunctional Tear Syndrome
Elvan Demiryay (2011)
10.1371/journal.pone.0208420
Is Sjögren’s syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests
D. Garcia (2018)
Jiménez-Alfaro, I. Benefits of omega-3 fatty acid dietary supplementation on health-related quality of life in patients with meibomian gland dysfunction
A Oleñik (2014)
Efficacy and safety of acupuncture at a single BL1 acupoint in the treatment of moderate to severe dry eye disease: Protocol for a randomized, controlled trial
X. Zhang (2018)
10.1016/j.jtos.2012.08.001
The origin of tears. III. The lipid component in the XIX and XX centuries.
J. Murube (2012)
Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: A Japanese Phase II clinical trial. Drug Des
H Toshida (2017)
10.3109/09286586.2010.498659
Prevalence of Dry Eye Disease in Mongolians at High Altitude in China: The Henan Eye Study
B. Guo (2010)
10.1097/OPX.0b013e318181ae36
Dry Eye Symptoms Assessed by Four Questionnaires
T. Simpson (2008)
10.3109/02713688509003350
The efficacy of retinoic acid ointment for treatment of xerophthalmia and corneal epithelial wounds.
J. Ubels (1985)
10.1016/j.ophtha.2016.07.028
Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
E. Messmer (2016)
Dry eye: prevalence, utilization, and economic implications.
J. Cramer (2003)
10.1002/14651858.CD009327.pub3
Autologous serum eye drops for dry eye.
Q. Pan (2017)
10.4018/978-1-5225-0432-0.CH011
Assessing the Appeal Power of Narrative Performance by using Eyeblink Synchronization among Audience
R. Nomura (2016)
10.4068/cmj.2015.51.1.26
Long-Term Outcome of Treatment with Topical Corticosteroids for Severe Dry Eye Associated with Sjögren's Syndrome
H. H. Jung (2015)
[Systemic treatment of ocular cicatricial pemphigoid].
M. C. Juri (2012)
10.1016/j.ajo.2008.08.015
A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
E. C. Kim (2009)
10.4103/ojo.OJO_29_2017
Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes
Saurabh Shrivastava (2018)
10.1097/00003226-200203000-00001
The Clinical Efficacy of Silicone Punctal Plug Therapy
Ming-Cheng Tai (2002)
10.1089/JOP.2016.0123
A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome.
SchmidlDoreen (2017)
10.1155/2019/1240537
Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma
A. Zaleska-Żmijewska (2019)
Soft steroid topical treatment for moderate to severe dry eye: pulse vs tapered therapy
E. Villani (2013)
10.1167/iovs.16-20303
Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease.
J. Benítez-del-Castillo (2016)
10.5301/ejo.5001002
One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease
C. Baudouin (2017)
10.3390/ijerph120707647
The Prevalence of Dry Eye Syndrome’s and the Likelihood to Develop Sjögren’s Syndrome in Taiwan: A Population-Based Study
J. Yen (2015)
10.18632/oncotarget.25544
Dry eye syndrome and the subsequent risk of chronic fatigue syndrome—a prospective population-based study in Taiwan
C. Chen (2018)
10.2147/OPTH.S113437
Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
Michelle K. Rhee (2017)
10.1007/s40265-015-0409-7
Diquafosol Ophthalmic Solution 3 %: A Review of Its Use in Dry Eye
G. Keating (2015)
The eye signs of vitamin A deficiency
C. Gilbert (2013)
10.1089/jop.2016.0086
A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye
Y. Park (2017)
10.1111/ceo.12183
Prevalence of dry eye syndrome in an adult population
H. Hashemi (2014)
10.1159/000310829
Effect of retinol palmitate as a treatment for dry eye: a cytological evaluation.
T. Kobayashi (1997)
10.1007/springerreference_39663
Schirmer's test
S. Stevens (2011)
10.1097/ICO.0b013e3181acf68d
Corneal and Conjunctival Sensitivity in Patients With Dry Eye: The Effect of Topical Cyclosporine Therapy
E. Toker (2010)
10.1016/S0002-9394(14)70509-4
Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome.
G. Bartley (1996)
10.1089/JOP.2017.0019
Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time.
KimYung Hui (2017)
10.1097/ICO.0b013e318165b1b7
Dry Eye Syndrome in Elderly Tibetans at High Altitude: A Population-based Study in China
P. Lu (2008)
10.1155/2015/704946
A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges
Suvarna P. Phadatare (2015)
10.1093/ajhp/41.1.178
Cyclosporine immunosuppression.
D. Canafax (1983)
10.1016/j.ajo.2013.12.023
Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life.
A. Paulsen (2014)
ects of a warm compress containing menthol on the tear film in healthy subjects and dry eye patients
R. Arita
10.3238/arztebl.2015.0071
The pathophysiology, diagnosis, and treatment of dry eye disease.
E. Messmer (2015)
Efficacy and safety of acupuncture at a single BL1 acupoint in the treatment of moderate to severe dry eye disease: Protocol for a randomized
X Zhang (2018)
10.1111/j.1755-3768.2012.02496.x
The wound healing effects of vitamin A eye drops after a corneal alkali burn in rats
E. C. Kim (2012)
10.1097/ICO.0b013e3181a16472
High-frequency Topical Cyclosporine 0.05% in the Treatment of Severe Dry Eye Refractory to Twice-daily Regimen
M. H. Dastjerdi (2009)
A study of prevalence of dry eye in relation to trachoma
D. B. Patel (2017)
10.1167/iovs.11-8829
A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation.
C. Di Tommaso (2012)
10.3390/ijms18071398
Dry Eye Management: Targeting the Ocular Surface Microenvironment
X. Zhang (2017)
10.1016/J.OPHTHA.2003.07.010
Methotrexate therapy for ocular cicatricial pemphigoid.
P. McCluskey (2004)
10.1177/147323000903700413
Discrimination between Sjögren's and Non-Sjögren's Sicca Syndrome by Sialoscintigraphy and Antibodies against α-Fodrin and Ro/La Autoantigens
K-S Chen (2009)
Chapter 6-Cyclosporine. In Therapy for Severe Psoriasis
V. V. Shah (2016)
10.1167/iovs.16-19788
Tear Interferometric Patterns Reflect Clinical Tear Dynamics in Dry Eye Patients.
R. Arita (2016)
10.1039/c9nr00376b
Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease.
Yu-Jia Li (2019)
10.1016/S1542-0124(12)70139-8
Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading.
G. Foulks (2003)
10.2147/IJN.S173198
Gelatin–epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief
Hsin-Yi Huang (2018)
10.1517/14656566.5.10.2099
Topical 0.05% cyclosporin in the treatment of dry eye
H. Perry (2004)
10.2147/OPTH.S5555
Etiology, prevalence, and treatment of dry eye disease
J. Gayton (2009)
Dry Eye: an Inflammatory Ocular Disease
Michelle Hessen (2014)
10.1371/journal.pone.0201340
Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study
H. Chen (2018)
10.13703/j.0255-2930.2017.10.011
[Comparison effects of acupuncture at distal acupoints and local acupoints on treatment of xerophthalmia].
C. Wang (2017)
10.1016/j.jtos.2017.05.008
TFOS DEWS II Definition and Classification Report.
J. Craig (2017)
10.1097/ICL.0000000000000042
The Core Mechanism of Dry Eye Disease Is Inflammation
Yi Wei (2014)
10.3390/nu11050942
Effects of Polyunsaturated Fatty Acids on Nonspecific Typical Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Sheng-Chu Chi (2019)
10.1097/ICO.0b013e318206caee
The Effect of Decreasing the Dosage of Cyclosporine A 0.05% on Dry Eye Disease After 1 Year of Twice-Daily Therapy
Michael Y Su (2011)
10.1016/j.jaut.2009.10.004
Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome.
Maria I. Christodoulou (2010)
10.1136/bjophthalmol-2015-306930
Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up
M. Straub (2016)
and conjunctival sensitivity in patients with dry eye : The e ff ect of topical cyclosporine therapy
E. Toker (2010)
Efficacy of Cyclosporine a (Restasis) for the Treatment of Dry Eye Symptoms in the First 30 Days of Therapy
L. Herrygers (2005)
10.1016/J.JACI.2009.12.186
Ocular Cicatricial Pemphigoid (OCP) Systemic Treatment
M. C. Juri (2010)
10.3390/jcm8010062
Gout as a Risk Factor for Dry Eye Disease: A Population-Based Cohort Study
C. Lee (2019)
10.1038/sj.bmt.1705900
Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease
Y. Wang (2008)
10.1155/2016/9312340
Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease
Naz Jehangir (2016)
10.1001/ARCHOPHT.1984.01040030746036
Treatment of xerophthalmia with retinol, tretinoin, and etretinate.
D. Hatchell (1984)
Rudan, I. Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: A systematic review and meta-analysis
P Song (2018)
10.1167/iovs.17-23760
Autologous Serum and Serum Components.
A. Higuchi (2018)
10.1016/J.SURVOPHTHAL.2007.04.009
The correlation between the tear film lipid layer and dry eye disease.
G. Foulks (2007)
10.2147/OPTH.S39699
P2Y2 receptor agonists for the treatment of dry eye disease: a review
Oliver C F Lau (2014)
10.1155/2017/5192924
Effect of Topically Administered Chitosan-N-acetylcysteine on Corneal Wound Healing in a Rabbit Model
Corinna Fischak (2017)
10.1001/archophthalmol.2009.52
Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
T. Hongyok (2009)
10.1016/S0002-9394(14)78304-7
Treatment of corneal xerophthalmia with topical retinoic acid.
A. Sommer (1983)
10.1167/iovs.08-2459
The contribution of lipid layer movement to tear film thinning and breakup.
P. King-Smith (2009)
10.1155/2016/7542929
Review: The Lacrimal Gland and Its Role in Dry Eye
Christopher D. Conrady (2016)
10.7717/peerj.5941
Association between dry eye disease and asthma: a nationwide population-based study
Yung-Chieh Huang (2018)
10.1097/00006324-199011000-00002
Meibomian Therapy in Problematic Contact Lens Wear
J. Paugh (1990)
10.1371/journal.pone.0207008
Osteoporosis and dry eye syndrome: A previously unappreciated association that may alert active prevention of fall
Yu-Ting Jeng (2018)
Correlation between dose and level of cyclosporine after orthotopic liver transplantation.
D. Kahn (1989)
10.1056/NEJMoa1709691
n‐3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease
P. Asbell (2018)
10.1007/978-3-540-47648-1_4777
PROSPECTIVE STUDY
X. García-Albéniz (2014)
10.1016/j.ophtha.2011.05.029
Prevalence and risk factors of dry eye disease in Japan: Koumi study.
M. Uchino (2011)
10.1080/10717544.2018.1458923
Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies
Yinglan Yu (2018)
10.2147/DDDT.S137825
Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial
H. Toshida (2017)
10.1038/s41598-017-09913-8
Epigallocatechin Gallate-Loaded Gelatin-g-Poly(N-Isopropylacrylamide) as a New Ophthalmic Pharmaceutical Formulation for Topical Use in the Treatment of Dry Eye Syndrome
Li-Jyuan Luo (2017)
10.1111/J.1601-0825.2006.01308_9.X
OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: a case report
S. Salzano (2006)
10.1097/OPX.0b013e318194e962
Blinking and Tear Break-Up During Four Visual Tasks
N. Himebaugh (2009)
10.1001/archophthalmol.2011.78
Prevalence of dry eye disease in an elderly Korean population.
S. Han (2011)
10.1097/ICO.0000000000001907
Efficacy of Vectored Thermal Pulsation and Warm Compress Treatments in Meibomian Gland Dysfunction: A Meta-Analysis of Randomized Controlled Trials
Shin-Pin Pang (2019)
10.1007/s40123-015-0038-y
The Future of Dry Eye Treatment: A Glance into the Therapeutic Pipeline
L. A. Vickers (2015)
10.1038/gt.2012.56
A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model
L. Contreras-Ruiz (2013)
Effect on conjunctival lymphocytes
K. S. Kunert (1960)
10.1097/00006324-199009000-00010
Prevalence of Meibomian Gland Dysfunction
M. Hom (1990)
10.1097/ICL.0000000000000228
Clinical Trial of Thermal Pulsation (LipiFlow) in Meibomian Gland Dysfunction With Preteatment Meibography
Y. Zhao (2016)
10.1089/jop.2017.0042
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
P. Steven (2017)
10.1016/S1542-0124(12)70138-6
Meibomian gland function and the tear lipid layer.
J. Mcculley (2003)
10.1039/c4sm00758a
Surface relaxations as a tool to distinguish the dynamic interfacial properties of films formed by normal and diseased meibomian lipids.
G. Georgiev (2014)
10.4103/0974-9233.167814
Dry Eye Syndrome and Allergic Conjunctivitis in the Pediatric Population
Handan Akil (2015)
10.1016/S0002-9394(01)01001-7
Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome.
L. C. Gordonson (2001)
10.1136/bjophthalmol-2018-313267
Punctal occlusion for dry eye syndrome: summary of a Cochrane systematic review
Ann-Margret Ervin (2018)
10.1111/cxo.12541
Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction
J. Albietz (2018)
10.1136/bjo.2004.044347
Autologous serum eye drops for ocular surface disorders
G. Geerling (2004)
10.1016/j.exer.2013.10.008
Complexity of the tear film: importance in homeostasis and dysfunction during disease.
D. Dartt (2013)
10.1001/archophthalmol.2009.356
Minimal clinically important difference for the ocular surface disease index.
K. L. Miller (2010)
10.1089/10807680260218515
Corneal protection by the ocular mucin secretagogue 15(S)-HETE in a rabbit model of desiccation-induced corneal defect.
D. Gamache (2002)
10.1001/ARCHOPHT.118.9.1264
Prevalence of and risk factors for dry eye syndrome.
S. Moss (2000)
10.1155/2014/683153
Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease: In Vitro Characterization Studies
Vijay D. Wagh (2014)
10.1097/00006324-200007000-00010
Prevalence of Dry Eye Subtypes in Clinical Optometry Practice
J. Albietz (2000)
10.1097/ICO.0b013e3181e7845b
The Effect of Topical Cyclosporine A on Clinical Findings and Cytological Grade of the Disease in Patients With Dry Eye
E. Şahlı (2010)
10.3109/02713683.2014.884595
Effects of Eye Drops Containing a Mixture of Omega-3 Essential Fatty Acids and Hyaluronic Acid on the Ocular Surface in Desiccating Stress-induced Murine Dry Eye
Zhengri Li (2014)
OPC-12759) in the treatment of dry eye: A randomized, double-masked, multicenter, placebo-controlled phase II study
S Kinoshita (2012)
Prevalence, burden, and pharmacoeconomics of dry eye disease.
S. Pflugfelder (2008)
10.1136/bjo.65.2.108
Meibomian glands and contact lens wear.
A. Henriquez (1981)
10.1016/J.NIOX.2007.04.006
Nitric oxide synthase induction and cytotoxic nitrogen-related oxidant formation in conjunctival epithelium of dry eye (Sjögren's syndrome).
J. Cejková (2007)
Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
A. Solomon (2001)
10.1016/j.ophtha.2015.02.037
Comparison of Two Questionnaires for Dry Eye Symptom Assessment: The Ocular Surface Disease Index and the Symptom Assessment in Dry Eye.
F. Amparo (2015)
10.1016/j.preteyeres.2010.03.001
Preservatives in eyedrops: The good, the bad and the ugly
C. Baudouin (2010)
10.2147/OPTH.S62470
Benefits of omega-3 fatty acid dietary supplementation on health-related quality of life in patients with meibomian gland dysfunction
Andrea Oleñik (2014)
Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.
R. Bowman (2000)
10.1185/03007995.2011.566264
Work productivity loss in patients with dry eye disease: an online survey
V. Patel (2011)
10.1097/ICU.0000000000000165
Treatment for meibomian gland dysfunction and dry eye symptoms with a single-dose vectored thermal pulsation: a review
C. Blackie (2015)
10.1097/ICO.0000000000000874
Influence of Omega 3 and 6 Fatty Acids on Human Meibomian Gland Epithelial Cells
Y. Liu (2016)
10.1089/jop.2016.0123
A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome.
D. Schmidl (2017)
10.1007/978-981-13-0950-2_14
New Combination/Application of Polymer-Based Nanoparticles for Biomedical Engineering.
R. Chang (2018)
10.1097/00003226-199705000-00022
Silicone Punctal Plug Migration Resulting in Dacryocystitis and Canaliculitis
S. Rumelt (1997)
10.1016/j.ophtha.2012.04.010
Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Y. Matsumoto (2012)
10.1097/MD.0000000000010875
Effect of laser acupuncture on dry eye
Wen-long Hu (2018)
10.3390/ijerph15102269
Association between Dry Eye Disease, Air Pollution and Weather Changes in Taiwan
Jia-Yu Zhong (2018)
10.1080/08820530590931368
Cicatricial Pemphigoid and Dry Eye
J. Dart (2005)
10.1007/978-3-540-69000-9_100548
Dry eye syndrome.
S. Watkinson (1985)
prevalence and treatment of dry eye disease
J L Gayton (2009)
The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop
(2007)
10.1016/j.preteyeres.2010.05.002
Presbyopia and cataract: A question of heat and time
R. Truscott (2010)
10.1097/OPX.0b013e3181824e0d
Clinically Important Difference in Dry Eye: Change in IDEEL-Symptom Bother
C. Fairchild (2008)
10.1016/j.exer.2019.05.018
Pigment epithelium-derived factor peptide reverses mouse age-related meibomian gland atrophy.
Nai-Wen Fan (2019)
10.1177/147323000903700413
Discrimination between Sjögren's and Non-Sjögren's Sicca Syndrome by Sialoscintigraphy and Antibodies against α-Fodrin and Ro/La Autoantigens
Chen Ks (2009)
10.1111/opo.12365
Omega‐3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study
Holly R Chinnery (2017)
10.1136/bjo.86.2.181
Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye
P. Aragona (2002)
10.1089/jop.2017.0019
Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time.
Yung Hui Kim (2017)
10.1016/j.anai.2012.01.006
Allergic conjunctivitis and dry eye syndrome.
M. Hom (2012)
10.1016/j.exer.2017.03.013
Structure-function relationship of tear film lipid layer: A contemporary perspective.
G. Georgiev (2017)
Minimal clinically important difference for the ocular surface disease
K. L. Miller (2010)
10.1111/cxo.12541
Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction
Julie M Albietz PhD BAppSc GradCertOcTher (2017)
10.1007/s00347-009-2019-9
[Meibomian glands. Part II: physiology, characteristics, distribution and function of meibomian oil].
E. Knop (2009)
10.1038/srep45848
Effects of a warm compress containing menthol on the tear film in healthy subjects and dry eye patients
R. Arita (2017)
10.7860/JCDR/2013/6089.3472
A Clinical Study of Subtype-based Prevalence of Dry Eye.
A. Rege (2013)
Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.
M. Lemp (1995)
10.1097/00130832-200410000-00017
Ocular cicatricial pemphigoid review
C. S. Foster (2004)
10.1167/iovs.13-11878
Tear film breakup and structure studied by simultaneous video recording of fluorescence and tear film lipid layer images.
P. King-Smith (2013)
10.1016/S0161-6420(03)00262-8
Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study.
P. Lin (2003)
10.1097/01.ICL.0000060998.20142.8D
Increase in Tear Film Lipid Layer Thickness Following Treatment with Warm Compresses in Patients with Meibomian Gland Dysfunction
M. C. Olson (2003)
10.1016/j.clae.2018.12.003
Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
C. Lievens (2018)
10.1001/ARCHOPHT.118.11.1489
Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes.
K. S. Kunert (2000)
10.2147/OPTH.S35584
Efficacy of retinol palmitate eye drops for dry eye in rabbits with lacrimal gland resection
A. Odaka (2012)
10.1097/ICO.0000000000001682
Effect of the Meibomian Gland Squeezer for Treatment of Meibomian Gland Dysfunction
Da-hu Wang (2018)
10.1590/S0004-27492008000700010
Autologous serum for ocular surface diseases.
G. Quinto (2008)
10.1089/jop.2018.0032
Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye
In Cheon You (2018)
10.1097/00003226-200310000-00008
Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests
A. Bron (2003)
Safety and E ffi cacy of Lacrimal Drainage System Plugs for Dry Eye Syndrome : A Report by the American Academy of
M. M. Marcet
Dry Eye. New Engl
J A Clayton (2018)
10.7189/jogh.08.020503
Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: a systematic review and meta-analysis
Peige Song (2018)
10.1001/ARCHDERM.142.10.1268
Successful treatment of mucous membrane pemphigoid with infliximab.
M. Heffernan (2006)
10.1016/S0161-6420(95)31024-X
Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis.
I. Toda (1995)
10.1016/j.jtos.2019.02.005
The optimum temperature for the heat therapy for meibomian gland dysfunction.
D. Borchman (2019)
10.1016/j.clae.2017.07.007
Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?
Laika Essa (2018)
10.3109/02713683.2010.544442
Blink Rate, Blink Amplitude, and Tear Film Integrity during Dynamic Visual Display Terminal Tasks
G. Cardona (2011)
10.2147/CMAR.S168477
Combination of recurrent oral aphthae and dry eye syndrome may constitute an independent risk factor for oral cavity cancer in elderly women
L. Qin (2018)
10.1007/s10620-008-0507-4
Rebamipide, a Cytoprotective Drug, Increases Gastric Mucus Secretion in Human: Evaluations with Endoscopic Gastrin Test
K. Iijima (2008)
10.1167/iovs.17-23623
Secreted Mucins on the Ocular Surface.
Y. Hori (2018)
10.1080/09273948.2018.1433302
Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy
L. Ma (2018)
10.1007/s12274-014-0547-3
Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndrome
Shengyan Liu (2014)
[Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid].
J. Celis Sánchez (2002)
10.1167/iovs.10-6997f
The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee.
A. Tomlinson (2011)
10.1007/978-1-4615-5359-5_41
Tear film interferometry as a diagnostic tool for evaluating normal and dry-eye tear film.
M. Doane (1998)
10.1097/OPX.0b013e318269c90d
Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) and Opinion of Contact Lens Performance
R. Chalmers (2012)
10.1007/s40123-013-0020-5
Intraocular Pressure Effects of Common Topical Steroids for Post-Cataract Inflammation: Are They All the Same?
U. Pleyer (2013)
10.1007/BF02204461
Keratoconjunctivitis sicca in rheumatoid arthritis
G. Mody (2005)
10.4137/OED.S16067
Safety and Efficacy of Cyclosporine in the Treatment of Chronic Dry Eye
C. Schultz (2014)
10.1007/978-1-4615-5359-5_117
Optimum dry eye classification using questionnaire responses.
C. McMonnies (1998)
10.2147/OPTH.S35685
Managing Sjögren’s Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy
Terry G. Coursey (2014)
10.1111/J.1600-0420.1997.TB00774.X
Keratoconjunctivitis sicca and primary Sjögren's syndrome in a Danish population aged 30-60 years.
K. Bjerrum (1997)
10.1001/ARCHOPHT.1989.01070020903037
Hygiene factors and increased risk of trachoma in central Tanzania.
H. Taylor (1989)
10.1097/OPX.0000000000000029
The Relation Between Blinking and Conjunctival Folds and Dry Eye Symptoms
H. Pult (2013)
10.1136/bjo.80.11.994
Allergic conjunctivitis and dry eye.
H. Fujishima (1996)
10.1097/IOP.0b013e3182a5ba6b
Bilateral simultaneous pyogenic granuloma after perforated punctal plug insertion.
Osama H. Ababneh (2014)
10.2147/OPTH.S33182
Emerging treatment options for meibomian gland dysfunction
J. Qiao (2013)
10.1016/j.clae.2017.09.006
The effects of a hydrating mask compared to traditional warm compresses on tear film properties in meibomian gland dysfunction.
Jacqueline Tan (2018)
10.2147/OPTH.S56783
Blink patterns and lid-contact times in dry-eye and normal subjects
G. Ousler (2014)
10.2147/OPTH.S39104
The interblink interval in normal and dry eye subjects
Patrick R. Johnston (2013)
10.1631/jzus.2006.B0675
A clinical study of the efficacy of topical corticosteroids on dry eye
C. Yang (2006)
10.1097/ICO.0000000000000409
Concordance Between Patient and Clinician Assessment of Dry Eye Severity and Treatment Response in Taiwan
Po-Ting Yeh (2015)
10.1016/B978-0-323-44797-3.00006-2
Chapter 6 – Cyclosporine
V. Shah (2016)
10.1097/ICO.0b013e3181f7f363
The Economic Burden of Dry Eye Disease in the United States: A Decision Tree Analysis
J. Yu (2011)
10.1016/J.EXER.2006.02.004
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.
C. S. de Paiva (2006)
10.1097/OPX.0000000000000667
Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Hsin-Yi Chen (2015)
10.1100/2012/194848
An Overview on Dry Eye Treatment: Approaches for Cyclosporin A Delivery
B. Yavuz (2012)
10.1167/iovs.10-6997d
The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease.
K. Green-Church (2011)
10.5935/0004-2749.20150078
Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
L. R. Parrilha (2015)
10.1080/09273948.2017.1341988
The Use of Topical Corticosteroids for Treatment of Dry Eye Syndrome
C. A. Cutolo (2019)
10.1016/j.clae.2010.01.003
Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
U. Benelli (2010)
10.1371/journal.pone.0157982
Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome
Ching-Li Tseng (2016)
Blink Patterns in Normal and Dry Eye Subjects; Beyond Blink Rate
R. White (2010)
10.2147/OPTH.S40798
Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal
T. Kashima (2014)
10.1016/j.sjopt.2018.06.001
Efficacy and safety of using topical cyclosporine A for treatment of moderate to severe dry eye disease
Tageldin M Othman (2018)
10.1016/j.ajo.2017.06.033
Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older.
Kimberly F. Farrand (2017)
ffi cacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye : A Japanese Phase II clinical trial
H. Toshida (2017)
10.1155/2013/521315
Topical 100% Serum Eye Drops for Treating Corneal Epithelial Defect after Ocular Surgery
K. Lekhanont (2013)
10.1016/j.ajo.2017.05.022
Classification of Fluorescein Breakup Patterns: A Novel Method of Differential Diagnosis for Dry Eye.
N. Yokoi (2017)
Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.
M. Stern (2002)
10.1016/j.ophtha.2015.04.034
Safety and Efficacy of Lacrimal Drainage System Plugs for Dry Eye Syndrome: A Report by the American Academy of Ophthalmology.
Marcus M. Marcet (2015)
10.1517/17425255.2015.1033397
Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients
L. Andrews (2015)
ff ectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
K. Ueda (2015)
10.1007/S11882-004-0077-2
Dry eye: Diagnosis and current treatment strategies
P. O'Brien (2004)
10.2147/OPTH.S185409
A randomized multicenter study comparing seawater washes and carmellose artificial tears eyedrops in the treatment of dry eye syndrome
M. Díaz-Llopis (2019)
Dry Eye Syndrome Risks in Patients With Fibromyalgia: A National Retrospective Cohort Study
C. H. Chen (2016)
10.1007/S10620-005-2800-9
15th Anniversary of Rebamipide: Looking Ahead to the New Mechanisms and New Applications
T. Arakawa (2005)
10.2147/TCRM.S1140
Treatment strategies in mucous membrane pemphigoid
A. Neff (2008)
Dry eye: prevalence, utilization, and economic implications.
M. Dalzell (2003)
10.1016/j.jtos.2016.06.002
Evaporation and Hydrocarbon Chain Conformation of Surface Lipid Films.
Samiyyah M. Sledge (2016)
10.1186/s12886-015-0040-0
Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
Kaori Ueda (2015)
10.1097/ICO.0000000000000173
Association of Dry Eye and Inflammatory Systemic Diseases in a Tertiary Care–Based Sample
C. Henrich (2014)
Alteration of mucin in human conjunctival epithelia in dry eye.
Y. Danjo (1998)
10.2147/OPTH.S1409
Treatment of chronic dry eye: focus on cyclosporine
G. Kymionis (2008)
Artificial Tear Use Improves Objective Signs and Visual Symptoms of Dry Eye
P. Simmons (2009)
10.1016/s1542-0124(12)70081-2
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007).
Michael A. Lemp (2007)
10.1038/nrd2280
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
A. Szallasi (2007)
10.1016/j.clae.2017.11.004
Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment.
Duygu Acar (2018)
10.1016/j.ophtha.2012.06.052
Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
S. Kinoshita (2012)
10.1007/s10792-019-01117-5
Population-based study on the epidemiology of dry eye disease and its association with presbyopia and other risk factors
Elsa L C Mai (2019)



This paper is referenced by
10.2147/OPTH.S185409
A randomized multicenter study comparing seawater washes and carmellose artificial tears eyedrops in the treatment of dry eye syndrome
M. Díaz-Llopis (2019)
10.12680/balneo.2020.340
The impact of the dry eye syndrome on the quality of life in elderly patients-minireview
C. Nicula (2020)
10.3390/ijerph15102269
Association between Dry Eye Disease, Air Pollution and Weather Changes in Taiwan
Jia-Yu Zhong (2018)
10.1208/s12249-020-01774-1
Intractable Ocular Diseases and Treatment Progress
Xinru Zhang (2020)
10.1007/s00717-020-00463-5
Keratokonjunktivitis sicca und Katarakt-Chirurgie – eine Übersicht der Problematik
Klemens Fondi (2020)
10.1016/j.clae.2017.11.004
Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment.
Duygu Acar (2018)
10.3390/jcm9020532
Why Internists Should Care About Dry Eye Disease
A. Galor (2020)
10.1016/j.sjopt.2018.06.001
Efficacy and safety of using topical cyclosporine A for treatment of moderate to severe dry eye disease
Tageldin M Othman (2018)
10.1097/MD.0000000000021878
The efficacy and safety of acupuncture or combined with western medicine for dry eye
X. Wang (2020)
10.1111/cxo.12541
Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction
J. Albietz (2018)
10.1136/bjophthalmol-2018-313267
Punctal occlusion for dry eye syndrome: summary of a Cochrane systematic review
Ann-Margret Ervin (2018)
A protocol of systematic review and meta-analysis
Ming-Xing He (2018)
10.1016/j.clae.2020.02.009
Ocular conditions and dry eye due to traditional and new forms of smoking: A review.
Dimitra Makrynioti (2020)
10.2147/IJN.S173198
Gelatin–epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief
Hsin-Yi Huang (2018)
Semantic Scholar Logo Some data provided by SemanticScholar